Targeted Therapeutics
Search documents
TransCode Therapeutics(RNAZ) - Prospectus
2024-01-11 13:22
Table of Contents As filed with the U.S. Securities and Exchange Commission on January 11, 2024. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 TRANSCODE THERAPEUTICS, INC. (Exact name of Registrant as specified in its charter) Delaware 2834 81-1065054 (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) 6 Liberty Square, #2382 Bos ...